Online citations, reference lists, and bibliographies.
← Back to Search

Apolipoprotein E, Survival In Alzheimer's Disease Patients, And The Competing Risks Of Death And Alzheimer's Disease

E. Corder, A. Saunders, W. Strittmatter, D. Schmechel, P. Gaskell, J. Rimmler, P. A. Locke, P. Conneally, K. Schmader, R. Tanzi, J. Gusella, G. Small, A. Roses, M. Pericak-Vance, J. Haines
Published 1995 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
The apolipoprotein E (APOE) ε4 allele carries an increased risk of a patient developing Alzheimer's disease (AD) while the ε2 allele carries a decreased risk. We compared survival from the onset of AD in subjects with different numbers of ε4 alleles and evaluated changes in genotypic frequencies with age. Two subject groups were investigated: unrelated AD case and control subjects, and affected and unaffected members from 74 multiplex AD families. In both subject groups, survival from onset decreased with increasing onset age, was longer in women, and was unrelated to ε4 gene dose. The ε2/ε3 genotype became more common with age (p = 0.004). The ε4 allele decreased in frequency with age in all patient groups but, unexpectedly, remained unchanged in control subjects. We conclude that the progression of AD is not strongly related to ε4 gene dose, that the higher prevalence of AD in women may involve the longer survival of affected women, and that AD and death are competing risks involving APOE that change over time.
This paper references
Nonparametric methods for regression
K. Jogdeo (1964)
Genetics of the apolipoprotein E system in man.
G. Utermann (1980)
Apolipoprotein E €4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the
M C Chartier-Harlin (1980)
10.1212/WNL.34.7.939
Clinical diagnosis of Alzheimer's disease
G. Mckhann (1984)
Diagnosis of Alzheimer's disease.
C. Filley (1988)
10.1126/SCIENCE.3283935
Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.
R. Mahley (1988)
Alzheimer's disease, apolipoprotein E4, a n d gender
H Payami (1988)
Nonparametric methods : one sample
RG Miller (1990)
10.1161/01.ATV.11.5.1237
Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.
J. Hixson (1991)
The PHREG procedure, Version 6
(1991)
Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease.
F. V. van Bockxmeer (1992)
creased amyloid b - peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late - onset Alzheimer disease
DE Schmechel (1992)
10.1016/0140-6736(93)91705-Q
Apolipoprotein E polymorphism and Alzheimer's disease
J. Poirier (1993)
10.1016/0140-6736(93)91458-X
Linkage of late-onset Alzheimer's disease with apolipoprotein E type 4 on chromosome 19
D. Borgaonkar (1993)
10.1016/0140-6736(93)91728-5
Apolipoprotein E genotype and Alzheimer's disease
Shigeji Noguchi (1993)
10.1093/CLINCHEM/39.10.2125
Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations.
G. Eggertsen (1993)
10.1073/PNAS.90.5.1977
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
W. Strittmatter (1993)
10.1016/0896-6273(93)90070-8
Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
G. W. Rebeck (1993)
10.1002/ANA.410340527
The apolipoprotein ε4 allele in patients with Alzheimer's disease
R. Mayeux (1993)
10.1126/SCIENCE.8346443
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
E. Corder (1993)
10.1002/GEPI.1370100104
Apo E allele frequencies in younger (age 42–50) vs older (age 65–90) women
J. Cauley (1993)
The apolipoprotein E E 4 al le le a n d sex - specific r i sk of Alzheimer ’ s disease [ letter ]
EH Corder (1993)
Associa - tion of apolipoprotein E allele € 4 with late - onset familial and sporadic Alzheimer ’ s disease
AM Saunders (1993)
Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E , apo - 45 : 1092 - 1096 . lipoprotein B , and cholesterol metabolism
E Boerwinkle (1993)
Increased amyloid b-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease
D E Schmechel (1993)
Apolipoprotein E genotype and Alzheimer ’ s disease [ letter ]
H Payami (1993)
10.1016/S0140-6736(94)91804-X
Protective effect of apoE ∈2 in Alzheimer's disease
R. Benjamin (1994)
10.1038/NG0694-180
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
E. Corder (1994)
10.1038/NG0194-29
Genetic associations with human longevity at the APOE and ACE loci
F. Schächter (1994)
10.1016/S0140-6736(94)92557-7
Protection against Alzheimer's disease with apoE ∈2
C. Talbot (1994)
10.1212/WNL.44.2.339
ApoE ϵ4 allelic association with Alzheimer's disease
M. L. Peacock (1994)
10.1212/WNL.44.2.342
Confirmation of the ϵ4 allele of the apolipoprotein E gene as a risk factor for late‐onset Alzheimer's disease
T. Brousseau (1994)
Confir - mation of association between the € 4 allele of apolipoprotein E and Alzheimer ’ s disease
M Liddell (1994)
Protective effect of apoE € 2 i n Alzheimer ’ s disease [ letter ]
GP Jarvik (1994)
Vidal 0, Amouyel P. Confirmation of the €4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease
T Brousseau (1994)
Finnish centenarians: a clinical epidemiological study. Helsinki: Geriatric Unit
J Louhija (1994)
2 chromosomal region
(1994)
10.1212/WNL.45.6.1092
Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease
G. Jarvik (1995)
10.1212/WNL.45.3.555
Synergistic Effects of Traumatic Head Injury and Apolipoprotein-epsilon4 in Patients With Alzheimer's Disease
R. Mayeux (1995)
APOE and Alzheimer disease : examination of allelic association and effect on age - at - onset in both early and late onset cases
C Talbot (1995)
Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apo-45
E Boerwinkle
lipoprotein B, and cholesterol metabolism



This paper is referenced by
10.1186/s13195-021-00857-w
Differential effects of risk factors on the cognitive trajectory of early- and late-onset Alzheimer’s disease
Jaeho Kim (2021)
10.1016/j.neurobiolaging.2020.10.032
Association of the CD2AP locus with cognitive functioning among middle-aged individuals with a family history of Alzheimer's disease
Sigalit Manzali (2020)
10.3233/JAD-201182
Modifiable, Non-Modifiable, and Clinical Factors Associated with Progression of Alzheimer's Disease.
D. Loeffler (2021)
10.1016/j.neurobiolaging.2020.06.001
Impact of APOE-ε4 carriage on the onset and rates of neocortical Aβ-amyloid deposition
S. Burnham (2020)
10.1111/febs.14794
Conformational analysis of apolipoprotein E3/E4 heteromerization
K. Tu (2019)
10.1016/j.neuron.2019.01.056
A Quarter Century of APOE and Alzheimer’s Disease: Progress to Date and the Path Forward
M. Belloy (2019)
10.1371/journal.pone.0194661
Class I HDAC inhibition is a novel pathway for regulating astrocytic apoE secretion
Erica Dresselhaus (2018)
10.3389/fnins.2018.00632
Iron and Alzheimer’s Disease: From Pathogenesis to Therapeutic Implications
Jun-Lin Liu (2018)
10.3233/JAD-161019
APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults.
S. Hollands (2017)
10.1007/978-1-4939-3661-8
Mouse Models for Drug Discovery
G. Proetzel (2016)
10.1007/978-1-4939-3661-8_18
Better Utilization of Mouse Models of Neurodegenerative Diseases in Preclinical Studies: From the Bench to the Clinic.
Christopher Janus (2016)
10.1016/j.jsbmb.2016.03.012
Age, APOE and sex: Triad of risk of Alzheimer’s disease
Brandalyn C. Riedel (2016)
10.1371/journal.pone.0157514
The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease
Luise Christine Löwe (2016)
10.1242/dmm.026674
HSV presence in brains of individuals without dementia: the TASTY brain series
J. Olsson (2016)
APOE4 induces tau hyperphosphorylation through calpain-CDK5 signaling pathway in EFAD-Tg mice
Meng Zhou (2016)
10.1016/B978-3-437-22484-3.00008-6
Kapitel 8 – Organische (und symptomatische) psychische Störungen
M. Huell (2015)
10.2174/1567205012666150302160145
Identification of novel quantitative traits-associated susceptibility loci for APOE ε 4 non-carriers of Alzheimer's disease.
Shan Jiang (2015)
10.1186/s13024-015-0002-2
APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice
De-shan Liu (2015)
10.3233/JAD-142442
Genetic Determinants of Survival in Patientswith Alzheimer’s Disease.
Xingbin Wang (2015)
10.1007/s11065-015-9279-8
Genetics and Functional Imaging: Effects of APOE, BDNF, COMT, and KIBRA in Aging
G. Papenberg (2015)
10.3233/JAD-132204
Chronic aluminum intake causes Alzheimer's disease: applying Sir Austin Bradford Hill's causality criteria.
J. Walton (2014)
10.1186/s40478-014-0075-0
Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice
Joanna E. Pankiewicz (2014)
10.1371/journal.pone.0094071
Regional-Specific Effects of Ovarian Hormone Loss on Synaptic Plasticity in Adult Human APOE Targeted Replacement Mice
R. Klein (2014)
10.1186/PREACCEPT-1147957959132865
Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε 2a ndε4 targeted replacement Alzheimer model mice
Joanna E. Pankiewicz (2014)
10.3389/fnagi.2014.00145
Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort
C. Aguilar (2014)
10.1007/s11682-013-9272-x
Apolipoprotein E, gender, and Alzheimer’s disease: an overlooked, but potent and promising interaction
Leo Ungar (2014)
The Absence of an Apolipoprotein E 4 Allele Is Associated with a More Aggressive Form of Alzheimer ' s Disease
Y. Stern (2013)
Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease
R. Mulnard (2013)
10.1002/ajmg.b.32191
A network medicine approach to psychiatric genetics
J. Lasky-Su (2013)
10.1017/S1355617713000581
Decreased Cognitive Function in Extended Family Members from the Single Late-Onset-Alzheimer's-Disease Pedigree
Y. Zeng (2013)
10.3174/ajnr.A3601
Higher Rates of Decline for Women and Apolipoprotein E ε4 Carriers
D. Holland (2013)
Studies on the use of glycosaminoglycans for the treatment of Alzheimer ’ s disease
Hao Cui MPharmSc (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar